Morning Roundup: November 10, 2023
by Nicholas Alan Clayton on 2023-11-10 at 7:34am

At the SPAC of Dawn

Good morning! Watch this space moving forward as a roundup of evening filings as well as news nuggets to nibble on beside your morning coffee.

After a Halloween massacre that saw four SPAC deals get terminated in about 24 hours, we presaged that the bloodletting of long-running deals might continue into November. So far, it has.

Yesterday two more deals went down as Blockchain Coinvestors (NASDAQ:BCSA) canceled a deal with Qenta and Arogo (NASDAQ:AOGO) threw in the towel on its EON reality deal. Both were transactions in sectors that appear to have far less buzz today than when they were struck.

Qenta is attempting to create a physical gold-backed crypto currency and fintech platform, while EON provides metaverse-based training programs.

The deals had each been pending for a year or more, which continues to be the state for a large portion of SPACs with announced deals. As of November 1, the median time since announcement for such SPACs had already grown to 7.3 months.

One more SPAC, Healthwell I (NASDAQ:HWEL) terminated its deal with Starton Therapeutics on Monday after a shorter campaign, having announced it initially in late April. This still brings the 10-day total to seven terminations.


News and Rumors

  • PR: Space venture Momentus (NASDAQ:MNTS) closed a sale of 2,904,269 warrants for about $6.5 million two years out from closing its combination with Stable Road. The warrants can be exercised to receive 5,808,538 shares at $2 per share.
  • The Messenger: SoftBank Group reported a loss of $1.55 billion in its second quarter on Thursday after taking a significant hit from WeWork’s (NYSE:WE), which combined with BowX in 2021, bankruptcy filing earlier this week.
  • PR: IoT company KORE (NYSE:KORE) announced a $150 million strategic investment from Searchlight Capital Partners that will reduce its leverage to 5.3x EBITDA from 7.3x. The company combined with Cerberus Telecom in 2021.
  • GasWorld: New Era Helium Corp., which announced the signing of a non-binding LOI for a proposed business combination with Accretion Acquisition (NASDAQ:ENER), is one step closer to production at its Pecos Slope helium plant, having announced the signing of two new agreements with Keyes Helium Company and Badger Midstream Energy.
  • Venture Beat: Skillz (NYSE:SKLZ) told a federal court on Monday that a federal grand jury was seeking access to information on AviaGames and its top executives in relation to Skillz’ allegations about defrauding players in skill-based games. Skillz completed its combination with Flying Eagle Acquisition Corp. in mid-December 2020.

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved